GlassScriptPhysician profile
Jodi Lynn Bleth
NPI 1073010468
$1,610.18
in general payments reported to CMS, 2019-2025
16 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $441 · 2022: $336 · 2023: $109 · 2024: $391 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $797 · Education: $35.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $796.91 |
| Education | $35.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $440.42 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $249.03 | 2021-2024 | Uzedy, Austedo Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $192.66 | 2021-2025 | Trintellix |
| Janssen Pharmaceuticals, INC | $159.60 | 2021-2025 | Spravato |
| Axsome Therapeutics, INC. | $131.69 | 2024-2025 | Auvelity |
| Sunovion Pharmaceuticals INC. | $109.87 | 2022 | |
| Lundbeck LLC | $80.39 | 2021-2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $70.03 | 2022-2024 | Rexulti |
| Vanda Pharmaceuticals INC. | $37.73 | 2021-2025 | Fanapt |
| Alkermes, INC. | $32.53 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $30.73 | 2021-2022 | |
| Alfasigma USA, INC. | $17.08 | 2021 | |
| Neurocrine Biosciences, INC. | $15.24 | 2024 | Ingrezza |
| Merck Sharp & Dohme LLC | $14.74 | 2021 | |
| Eisai INC. | $14.47 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $13.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodi Bleth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.